Semaglutide in MASLD

Created using ChatSlide

This comprehensive overview explores the role of Semaglutide, a GLP-1 receptor agonist, in managing MASLD (metabolic-associated steatotic liver disease), particularly its impact on Type 2 Diabetes Mellitus (T2DM). It delves into the pathogenesis of MASLD, highlighting lipid metabolism dysfunctions and the shift to a multiple-hit model. Additionally, it reviews the benefits of Semaglutide, including glycemic control and anti-inflammatory effects, while also addressing its limitations and...